Heroin

Edit My Profile

"Heroin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed)

Descriptor ID	D003932
MeSH Number(s)	D03.132.577.249.562.445 D03.605.497.607.490 D03.633.400.686.607.490 D04.615.723.795.576.445
Concept/Terms	Heroin Heroin Diacetylmorphine Diamorphine Diagesil Diagesil Diamorf Min-I-Jet Morphine Sulphate Min-I-Jet Morphine Sulphate Min I Jet Morphine Sulphate Heroin Hydrochloride Heroin Hydrochloride Hydrochloride, Heroin Diacetylmorphine Hydrochloride Hydrochloride, Diacetylmorphine

Below are MeSH descriptors whose meaning is more general than "Heroin".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Alkaloids [D03.132]
Opiate Alkaloids [D03.132.577]
Morphinans [D03.132.577.249]
Morphine Derivatives [D03.132.577.249.562]
Heroin [D03.132.577.249.562.445]
Heterocyclic Compounds, Bridged-Ring [D03.605]
Morphinans [D03.605.497]
Morphine Derivatives [D03.605.497.607]
Heroin [D03.605.497.607.490]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 4 or More Rings [D03.633.400]
Morphinans [D03.633.400.686]
Morphine Derivatives [D03.633.400.686.607]
Heroin [D03.633.400.686.607.490]
Polycyclic Compounds [D04]
Polycyclic Aromatic Hydrocarbons [D04.615]
Phenanthrenes [D04.615.723]
Morphinans [D04.615.723.795]
Morphine Derivatives [D04.615.723.795.576]
Heroin [D04.615.723.795.576.445]

Below are MeSH descriptors whose meaning is related to "Heroin".

Below are MeSH descriptors whose meaning is more specific than "Heroin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heroin" by people in this website by year, and whether "Heroin" was a major or minor topic of these publications.

Bar chart showing 15 publications over 11 distinct years, with a maximum of 2 publications in 2005 and 2016 and 2021 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	1	1
2005	2	0	2
2006	0	1	1
2008	1	0	1
2016	1	1	2
2017	1	0	1
2020	0	1	1
2021	0	2	2
2022	0	2	2
2023	0	1	1

Below are the most recent publications written about "Heroin" by people in Profiles.

D'Orazio J, Nelson L, Perrone J, Wightman R, Haroz R. Xylazine Adulteration of the Heroin-Fentanyl Drug Supply : A Narrative Review. Ann Intern Med. 2023 10; 176(10):1370-1376.

View in: PubMed
Kacinko SL, Mohr ALA, Logan BK, Barbieri EJ. Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework. J Anal Toxicol. 2022 Oct 14; 46(8):911-917.

View in: PubMed
Calello DP, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, Brent J, Wax P, Walton S, Manini AF. Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose. Clin Toxicol (Phila). 2022 09; 60(9):1067-1069.

View in: PubMed
Krotulski AJ, Chapman BP, Marks SJ, Ontiveros ST, Devin-Holcombe K, Fogarty MF, Trieu H, Logan BK, Merchant RC, Babu KM. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose. Clin Toxicol (Phila). 2022 Feb; 60(2):197-204.

View in: PubMed
Midthun KM, Nelson LS, Logan BK. Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review. Ther Drug Monit. 2021 04 01; 43(2):221-228.

View in: PubMed
Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busard? FP. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Ther Drug Monit. 2020 04; 42(2):205-221.

View in: PubMed
Griswold MK, Chai PR, Krotulski AJ, Friscia M, Chapman B, Boyer EW, Logan BK, Babu KM. Self-identification of nonpharmaceutical fentanyl exposure following heroin overdose. Clin Toxicol (Phila). 2018 Jan; 56(1):37-42.

View in: PubMed
Mohr AL, Friscia M, Papsun D, Kacinko SL, Buzby D, Logan BK. Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework. J Anal Toxicol. 2016 Nov; 40(9):709-717.

View in: PubMed
Eriksen GS, Andersen JM, Boix F, Bergh MS, Vindenes V, Rice KC, Huestis MA, M?rland J. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice. J Pharmacol Exp Ther. 2016 08; 358(2):209-15.

View in: PubMed
Brunet BR, Barnes AJ, Scheidweiler KB, Mura P, Huestis MA. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal Bioanal Chem. 2008 Sep; 392(1-2):115-27.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement